Close
 

Table 1: Tyrosine kinase inhibitors that have been studied in clinical and experimental models of type 1 diabetes and type 2 diabetes

Table 1: Tyrosine kinase inhibitors that have been studied in clinical and experimental models of type 1 diabetes and type 2 diabetes